Environmental groups said Bayer wants to keep juries out of the lawsuits because it keeps losing in state courts. “It’s a sad day in America when our highest court agrees to consider depriving thousands of Roundup users suffering from cancer of their day in court,” said Lori Ann Burd, environmental health director at the Center for Biological Diversity.
Bayer acquired Roundup as part of its $63 billion purchase of agrochemical company Monsanto in 2018.
Corporate conductAllegation
A California jury instructed Bayer to pay $2 billion in damages
In the largest payout, in May 2019, a California jury instructed Bayer to pay $2 billion in damages, later cut to $87 million on appeal, to a local couple on the grounds that the company had failed to adequately advise consumers of Roundup’s possible carcinogenic risks.
In the largest payout, in May 2019, a California jury instructed Bayer to pay $2 billion in damages, later cut to $87 million on appeal, to a local couple on the grounds that the company had failed to adequately advise consumers of Roundup’s possible carcinogenic risks.
Corporate conductConfirmed
Bayer withholds emergency information from agencies
Bayer withheld information from county emergency response agencies during a fire incident.
“The Bayer fire brigade was at the scene in minutes, but Bayer management withheld information from the county emergency response agencies that were desperate for information about what happened, what chemicals were possibly involved,” Mr. Bresland said.
Corporate conductConfirmed
Bayer pays $100 million for school chemical injuries
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure to toxic chemicals made by the company’s Monsanto unit caused brain damage and other injuries.
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain damage and other injuries.
Corporate conductAllegation
Bayer is accused of downplaying cerivastatin risks
Bayer is accused of downplaying cerivastatin's risk of rhabdomyolysis and misrepresenting its efficacy compared to other statins.
The lawsuit further alleged that Bayer submitted false claims to the Medicare and Medicaid programs and violated the laws of 20 states and the District of Columbia.
In a second lawsuit, Simpson alleged that Bayer knew about, but downplayed, cerivastatin's risks of causing rhabdomyolysis; misrepresented the efficacy of cerivastatin when compared to other statins; and fraudulently persuaded the Defense Logistics Agency to renew certain contracts relating to cerivastatin.
"As alleged in the complaints, Bayer — one of the largest pharmaceutical companies in the world — engaged in a series of unlawful acts, including paying kickbacks to doctors and hospitals, marketing them off-label, and downplaying their safety risks," Philip R. Sellinger, US attorney for the District of New Jersey, said in the statement.
Corporate conductSettlement
Bayer settles fraud allegations for $40 million
Bayer settles kickback and fraud allegations for $40 million.
Today, the Department of Justice announced that during the course of the Antitrust Division’s ongoing investigation into exclusionary conduct in corn and soybean seed markets, Bayer CropScience LLC has removed potentially anticompetitive provisions from its loyalty program.
The parties also are settling allegations that Bayer knowingly underpaid the Medicaid program for rebates owed by it to the states.
Workplace equityAllegation
Six Bayer employees file $100 million gender-discrimination lawsuit
Six former and current employees of Bayer's health-care arm filed a $100 million gender-discrimination lawsuit, claiming the U.S. unit discriminates against female employees in pay, promotion, and pregnancy leave.
Six former and current employees of Bayer…health-care arm filed a $100 million gender-discrimination lawsuit Monday, claiming the U.S. unit discriminates against its female employees in terms of pay and promotion, as well as pregnancy leave.
Lawsuit Claims Discrimination by Bayer [USA] - Business and Human Rights Centre
Corporate conductConfirmed
Bayer faces 50% fine hike for cartel violations
Bayer receives a 50% increase in fines by the Commission for cartel activities previously fined.
As a result of the settlement announced today, Bayer and Monsanto will pay $6.9 million to OAG, which will be used to prevent, abate, restore, mitigate, or control the impacts of toxic pesticides such as those containing glyphosate on pollinators or aquatic species. The specific programs and projects that will be supported with these funds have yet to be determined, but may include research, monitoring, and education, as well as habitat management, restoration, and enhancement.
Attorney General James Secures $6.9 Million from Bayer and Monsanto for False Advertising of Roundup® Weedkillers
As a result of the settlement announced today, Bayer and Monsanto will pay $6.9 million to OAG, which will be used to prevent, abate, restore, mitigate, or control the impacts of toxic pesticides such as those containing glyphosate on pollinators or aquatic species.
In 2020, Attorney General James began an investigation into whether Monsanto, and its current owner Bayer, were again engaging in false advertising of their Roundup® products, in violation of Monsanto’s 1996 settlement with OAG.
NEW YORK – New York Attorney General Letitia James today announced a settlement with Bayer CropScience LP (Bayer) and Monsanto Company (Monsanto) for allegedly making false and misleading claims regarding the safety of certain Roundup® consumer weedkillers.
Once again, Monsanto and the company’s current owner, Bayer, made false and misleading claims about the safety of their products, but we will not allow them to get away with endangering our environment.
The grants are part of the New York Pollinator Conservation Fund, a multi-million-dollar initiative launched by the Office of the Attorney General (OAG) using proceeds from a 2023 settlement with Bayer CropScience and Monsanto for misleading the public about the safety of certain Roundup® consumer weedkillers, which can be toxic to pollinator species like bees and butterflies.
_______________________________________________ ASSURANCE OF DISCONTINUANCE The Office of the Attorney General of the State of New York (“OAG”) commenced an investigation pursuant to Executive Law §§ 63(12) and (15) and General Business Law (“GBL”) Article 22-A into potential violations of a November 19, 1996 Assurance of Discontinuance (“1996 AOD”) entered into by Monsanto Company, as well as allegedly false and misleading claims made by Bayer CropScience LP and Monsanto Company (collectively, “Respondents”) in advertisements for Roundup® pesticide products containing the active ingredient glyphosate.
The millions of dollars that Bayer and Monsanto will pay to the New York attorney general’s office will go toward remedying the impacts of environmental toxins or pollution on pollinating insects and aquatic species.
Yet Bayer and Monsanto repeatedly advertised glyphosate-based Roundup products as safe and nontoxic without adequate substantiation, Attorney General Letitia James determined in an investigation that started three years ago.
“Bayer made numerous misleading claims to consumers about the safety of its pesticide products, including falsely advertising that they were similar to giving ‘a daily vitamin’ to plants, when in fact, they are highly toxic to honey bees and other pollinators in the environment,” said AG Healey.
Corporate conductAllegation
Bayer is accused of raising costs for farmers
Latham alleged Bayer raised costs for farmers and independent seed companies by controlling the market for corn seeds engineered to resist Roundup.
Latham alleged Bayer raised costs for farmers and independent seed companies by controlling the market for corn seeds engineered to resist its widely used weedkiller Roundup, according to its lawsuit filed in the U.S. District Court for the Eastern District of Missouri.
Bayer sued for allegedly monopolizing US market for GMO corn seeds
Latham alleged Bayer raised costs for farmers and independent seed companies by controlling the market for corn seeds engineered to resist its widely used weedkiller Roundup, according to its lawsuit filed in the U.S. District Court for the Eastern District of Missouri.
Bayer Sued for Allegedly Monopolizing US Market for GMO Corn Seeds - AgWeb
Corporate conductAllegation
Bayer is accused of recalling 6 mL Afrin Original nasal spray bottles
Bayer is accused of recalling 6 mL Afrin Original nasal spray bottles due to a risk of serious injury or illness from child poisoning, violating mandatory child-resistant packaging standards.
Bayer Healthcare is recalling Travel Size Afrin Original Nasal Spray because the 6-mL bottles were not sold in child-resistant packaging despite containing imidazoline, a nasal decongestant.
Bayer recalls Afrin nasal spray over child safety concerns - al.com About 786,100 nasal spray bottles are being recalled due to safety risks to children, according to the U.S. Consumer Product Safety Commission.
Bayer Recalls 6 mL Size Afrin Original Nasal Spray Bottles Due to Risk of Serious Injury or Illness from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
Bayer Recalls 6 mL Size Afrin Original Nasal Spray Bottles Due to Risk of Serious Injury or Illness from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
1, 2021, Bayer initiated a recall of all unexpired Lotrimin AF and Tinactin spray products distributed between September 2018 and September 2021 with lot numbers beginning with TN, CV, or NAA.
Bayer first recalled Lotrimin AF and Tinactin antifungal spray products in October 2021, after they were found to have an undeclared ingredient.
Bayer agrees to $4.85M in fungal spray lawsuit. How to claim payout
Corporate conductRuling
The European Commission fined Bayer for market sharing and price fixing in the chloroprene rubber market
Antitrust: Commission fines producers of chloroprene rubber € 247.6 million for market sharing and price fixing in the EEA The European Commission has imposed a total of € 247 635 000 fines on the Bayer, Denka, DuPont, Dow, ENI and Tosoh groups for participating in a cartel for chloroprene rubber in the European Economic Area (EEA) in violation of the EC Treaty’s ban on cartels and restrictive business practices (Article 81).
chloroprene rubber € 247.6 million for market sharing and price fixing in the EEA The European Commission has imposed a total of € 247 635 000 fines on the Bayer, Denka, DuPont, Dow, ENI and Tosoh groups for participating in a cartel for chloroprene rubber in the European Economic Area (EEA) in violation of the EC Treaty’s ban on cartels and restrictive business practices (Article 81).
Antitrust: Commission fines producers of chloroprene rubber € 247.6 million for market sharing and price fixing in the EEA The European Commission has imposed a total of € 247 635 000 fines on the Bayer, Denka, DuPont, Dow, ENI and Tosoh groups for participating in a cartel for chloroprene rubber in the European Economic Area (EEA) in violation of the EC Treaty’s ban on cartels and restrictive business practices (Article 81).
Boston — Bayer CropScience, the world’s largest agrochemical company and one of the largest global manufacturers of pesticides, has agreed to pay $75,000 and change its advertising practices to resolve allegations that the company misled and deceived consumers about the potential risks its pesticides pose to bees and the environment, Attorney General Maura Healey announced today.
Press Release AG Takes Action Against Bayer Over Deceptive Marketing About Risks of Pesticides First-of-Its-Kind Enforcement Action by a State Attorney General Targeting a Manufacturer of Neonicotinoid Pesticides
Bayer believes it has suffered monetary damages as a result of Defendants’ acts of false advertising in an amount not yet determined but that already exceeds $75,000.
Bayer believes it has suffered monetary damages as a result of Defendants’ acts of unfair competition in an amount not yet determined but that already exceeds $75,000.
Corporate conductConfirmed
Bayer misrepresents due diligence to investors
A federal judge advanced claims that Bayer misrepresented its due diligence efforts to investors before acquiring Monsanto in 2018.
In view of the serious doubts arising from Bayer's position in these markets post- merger, the Commission decided to initiate proceedings in accordance with the Merger Regulation.
Corporate conductConfirmed
Bayer discloses capital increase plans
Germany's financial markets watchdog launched an initial probe into whether Bayer fairly disclosed plans for a potential capital increase seeking shareholder approval.
FRANKFURT (Reuters) -Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get shareholder approval for a potential capital increase, a regulatory source told Reuters on Tuesday.
Corporate conductConfirmed
Bayer — Medicaid
The German pharmaceutical giant Bayer is to plead guilty to criminal charges and pay $257m (£165m; €236m) in fines and civil damages for overcharging Medicaid, the US state and federally funded health insurance plan for patients with low income aged under 65 years.
The German pharmaceutical giant Bayer is to plead guilty to criminal charges and pay $257m (£165m; €236m) in fines and civil damages for overcharging Medicaid, the US state and federally funded health insurance plan for patients with low income aged under 65 years.
Bayer made a deep discount to keep the health maintenance organisation's business, but as the price was lower than that which Medicaid paid for ciprofloxacin, Bayer would have owed tens of millions of dollars in rebates to Medicaid.
The German pharmaceutical giant Bayer is to plead guilty to criminal charges and pay $257m (£165m; €236m) in fines and civil damages for overcharging Medicaid, the US state and federally funded health insurance plan for patients with low income aged under 65 years.